Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/28/2012CN102085355B Liraglutide long-acting microsphere injection and preparation method thereof
11/28/2012CN102078598B Injection for preventing and treating porcine viral diseases and preparation method thereof
11/28/2012CN102040654B Polypeptide TF1 for inhibiting activity of shiga toxin (stx) 2 and coding gene and application of stx2
11/28/2012CN101948512B Polypeptide WA8 for inhibiting type-2 shiga toxin activity and coding gene and application thereof
11/28/2012CN101934071B Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome
11/28/2012CN101812122B Protection effect of light-harvesting chromoprotein of algae on lens epithelial cells
11/28/2012CN101703777B Tamper-resistant oral opioid agonist formulations
11/28/2012CN101641372B Template-fixed peptidomimetics
11/28/2012CN101636180B Peptide compounds for treating refractory status epilepticus
11/28/2012CN101624419B Group of novel uncyclized antibiotic peptides containing gamma-core motif and preparation method as well as application thereof
11/28/2012CN101386644B Pumpkin protein 2 and preparation method and application thereof
11/28/2012CN101384275B Dissolution aids for oral peptide delivery comprising a biguanide
11/28/2012CN101139625B Ace inhibitory peptides from plant materials
11/28/2012CN101010340B Glp-1 and exendin related invention
11/27/2012US8321143 Synthetic active peptide fragments
11/27/2012US8318922 Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318904 Liquid, aqueous pharmaceutical compositions of factor VII polypeptides
11/27/2012US8318903 Benign solvents for forming protein structures
11/27/2012US8318902 Biomaterial
11/27/2012US8318901 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
11/27/2012US8318899 Lytic domain fusion constructs and methods of making and using same
11/27/2012US8318816 Enhanced transport using membrane disruptive agents
11/27/2012US8318704 Modulation of neural stem cells and neural progenitor cells
11/27/2012US8318691 Treatment of tumors with genetically engineered herpes virus
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318681 Utilization of peptides as active ingredients for slimming
11/27/2012US8318680 Method and peptide for regulating cellular activity
11/27/2012US8318679 Trimerising module
11/27/2012US8318678 Cosmetic compositions
11/27/2012US8318677 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
11/27/2012US8318676 Use of agents containing creatine, creatinine and/or their derivatives to fortify and improve the structure of keratinic fibers
11/27/2012US8318675 Crustacean androgenic gland hormone, associated peptides, and use thereof
11/27/2012US8318674 Local treatment of bone defects
11/27/2012US8318673 Anti-hemorrhage medication pack
11/27/2012US8318672 Cellular factor-containing solution compositions
11/27/2012US8318671 Pharmaceutical preparations comprising human proNGF
11/27/2012US8318670 Antigens targeted by pathogenic AI4 T cells in type 1 diabetes and uses thereof
11/27/2012US8318669 Method of regulating glucose metabolism, and reagents related thereto
11/27/2012US8318668 Stabilized GLP-1 analogs
11/27/2012US8318667 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
11/27/2012US8318666 Use of leptin to treat metabolic abnormalities associated with lipoatrophy
11/27/2012US8318665 Cytokine containing compositions
11/27/2012US8318664 Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity
11/27/2012US8318663 Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent
11/27/2012US8318661 Candidates against infection
11/27/2012US8318660 Method of treating a disease by administering caspase-8
11/27/2012US8318659 Peptide-based organic sunscreens
11/27/2012US8318640 Methods for selective targeting
11/27/2012US8318457 FSH producing cell clone
11/27/2012US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/27/2012US8318197 Wound healing device and method
11/27/2012US8318177 Viral chemokine-antigen fusion proteins
11/27/2012US8318176 Immunosuppressive polypeptides and nucleic acids
11/27/2012US8318175 Method for treating amyloid disease
11/27/2012US8318174 Survivin-derived peptides and use thereof
11/27/2012US8318171 Neurotoxic oligomers
11/27/2012US8318169 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
11/27/2012US8318158 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
11/27/2012US8318157 Trichoderma reesei α-amylase enhances saccharification of corn starch
11/27/2012US8318156 Anti-cocaine compositions and treatment
11/27/2012US8318155 Nucleic acid cleaving agent
11/27/2012US8318154 Super fast-acting insulin compositions
11/27/2012US8318147 Use of IL-29 for treating a dengue virus infection
11/27/2012US8318135 Antagonist of ligands and uses thereof
11/27/2012CA2689358C Peptide pharmaceutical for oral delivery
11/27/2012CA2666415C Agent containing fused protein of soluble rankl with epitope tag
11/27/2012CA2634169C Method for treating disseminated cancer
11/27/2012CA2581934C Stretch mark treatment with botulinum toxin
11/27/2012CA2558212C Interferon-beta for anti-virus therapy for respiratory diseases
11/27/2012CA2516702C Modified t cell receptor linked by disulphide bond between constant domain cysteine residues
11/27/2012CA2516458C Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
11/27/2012CA2488404C Genes and polypeptides relating to human colon cancers
11/27/2012CA2432525C Streptococcus pyogenes antigens and corresponding dna fragments
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/27/2012CA2333755C The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
11/27/2012CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof
11/27/2012CA2181832C Immunization by inoculation of dna transcription unit
11/22/2012WO2012159103A1 Dry powder vancomycin compositions and associated methods
11/22/2012WO2012159100A1 Il-12 p40 monomer, monoclonal antibody against p40 homodimer and the combination of the two for autoimmune disease treatment
11/22/2012WO2012159053A1 Process for purifying heparan-n-sulfatase
11/22/2012WO2012159044A1 Stem cell mobilization and tissue repair and regeneration
11/22/2012WO2012158952A1 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
11/22/2012WO2012158789A2 Methods and compositions for inhibiting neddylation of proteins
11/22/2012WO2012158216A1 Methods of treating a disorder associated with sequestered bacteria
11/22/2012WO2012158169A1 Methods and compositions for tissue repair
11/22/2012WO2012158123A1 Compounds and methods for treating insulin resistance syndrome
11/22/2012WO2012158048A1 A dietary supplement
11/22/2012WO2012157752A1 Pharmaceutical composition containing loxoprofen
11/22/2012WO2012157737A1 Immunity inducing agent
11/22/2012WO2012157736A1 Immunity induction agent
11/22/2012WO2012157674A1 Cyclic peptide compound or pharmacologically acceptable salt thereof, method for producing cyclic peptide compound or pharmacologically acceptable salt thereof, and use of cyclic peptide compound or pharmacologically acceptable salt thereof
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012157237A1 Osteogenesis promoter
11/22/2012WO2012157136A1 Rrecombinant human saposin b protein containing phosphorylated glucose ring and use thereof
11/22/2012WO2012156927A1 Method to modulate pigmentation process in the melanocytes of skin
11/22/2012WO2012156825A1 Peptide-based hiv pre-integration complex inhibitors
11/22/2012WO2012156811A2 Compositions useful for the treatment of inflammatory disease or disorders
11/22/2012WO2012156731A1 Honey composition with l-alanyl- l- glutamine
11/22/2012WO2012156641A1 Use of kappa-elastin for the reconstruction and/or regeneration of periodontal tissues
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 3163